Prd Plus 325 mg/37.5 mg Tablet
By Prd Plus
Rx
10 Tablet in a Strip

Composition
Paracetamol/Acetaminophen(325mg) + Tramadol(37.5mg)

Manufacturer - Mission Research Laboratories Pvt Ltd
Mission Research Laboratories (I) Pvt. Ltd., Plot No. 45, N.T.M, Sector – 26, Chandigarh 160019.

Expires on or after
July, 2025

liver
When using Prd Plus 325 mg/37.5 mg Tablet, it's important to be cautious if you have liver disease. Make sure to consult your doctor as dose adjustment may be necessary for your condition. It's recommended not to use Prd Plus 325 mg/37.5 mg Tablet if you have severe liver disease or active liver disease. Consulting with your doctor is vital to ensure the safe use of Prd Plus 325 mg/37.5 mg Tablet in case of any liver issues.

kidney
Prd Plus 325 mg/37.5 mg Tablet should be used carefully in individuals with kidney problems. Adjusting the dosage may be necessary. It's important to consult your doctor before using Prd Plus 325 mg/37.5 mg Tablet.

alcohol
"Caution It is unsafe to drink alcohol while taking Prd Plus 325 mg/37.5 mg Tablet. Avoid alcohol consumption to prevent any harm or side effects."

driving
When taking Prd Plus 325 mg/37.5 mg Tablet, be cautious while driving as it may cause side effects that could impact your ability to operate a vehicle safely. Always prioritize your safety and the safety of others on the road.

pregnancy
Using Prd Plus 325 mg/37.5 mg Tablet during pregnancy may be unsafe. Animal studies indicate harmful effects on the developing baby. Consult your doctor for a thorough evaluation of benefits versus risks before using.

breastfeeding
Prd Plus 325 mg/37.5 mg Tablet is considered safe during breastfeeding based on limited human data. Consult a doctor if the baby shows signs of unusual sleepiness, breastfeeding difficulties, breathing issues, or limpness.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹53.9
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 18-Nov-2024